Ticker Symbol: MEDP
Medpace Holdings Inc
$224.88 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001668397
Company Profile
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 8731
Address: 5375 Medpace Way
Website: www.medpace.com
CEO: August Troendle
Tags:
- Commercial Services
- Miscellaneous Commercial Services
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $239.10
Change:
$1.04
(
0.44%)
Days Range: $234.20 - $240.52
Beta: 1.25
52wk. High: $282.73
52wk. Low: $155.84
Ytd. Change 13.00%
50 Day Moving Average: $251.95
200 Day Moving Average: $233.40
Shares Outstanding: 30562773
Valuation
Market Cap: 730.8B
PE Ratio: 28.57
EPS (TTM): 8.37
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A